Phenytoin (Taro Pharmaceuticals U.S.A., Inc.)
Welcome to the PulseAid listing for the Phenytoin drug offered from Taro Pharmaceuticals U.S.A., Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Taro Pharmaceuticals U.S.A., Inc. |
NON-PROPRIETARY NAME: | Phenytoin |
SUBSTANCE NAME: | PHENYTOIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | SUSPENSION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-04-08 |
END MARKETING DATE: | 0000-00-00 |
Phenytoin HUMAN PRESCRIPTION DRUG Details:
Item Description | Phenytoin from Taro Pharmaceuticals U.S.A., Inc. |
LABELER NAME: | Taro Pharmaceuticals U.S.A., Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/5mL) |
START MARKETING DATE: | 2004-04-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51672-4069_a1a1cc6e-22ce-4abc-b108-709188198396 |
PRODUCT NDC: | 51672-4069 |
APPLICATION NUMBER: | ANDA040521 |
Other PHENYTOIN Pharmaceutical Manufacturers / Labelers: